News on sequencing-based testing, NGS gene panels, & diagnostic exomes in genetics, genomics, and molecular diagnostics.
Foundation Medicine Blood Test Gets FDA Approval as CDx for Pfizer's Braftovi in Colorectal Cancer
The FDA has approved the FoundationOne Liquid CDx assay to identify patients with BRAF V600E alterations eligible for treatment with Braftovi.
IMBdx, AstraZeneca Expand Prostate Cancer Liquid Biopsy Partnership
Following an evaluation of the Korean firm's test, the two companies are partnering to increase awareness among clinicians and patients.
BGI Genomics Forges Partnerships for Precision Medicine in Latin America
Through the collaborations, the Chinese NGS service provider is introducing its oncology and noninvasive prenatal tests to Brazil, Argentina, and Chile.
Using Arima's technology, NYU researchers were able to identify a novel rearrangement in the PDL-1 gene in a pediatric brain tumor, which led to treatment with immunotherapy.
AMP, NSGC Issue New Recommendations for Confirming Germline Variants From NGS Tests
The guidelines are the product of a working group convened by the Association for Molecular Pathology that assessed the literature, surveys, and public comment.